Despite the massive interest and recent developments in the field of nanomedicine, only a
limited number of formulations have found their way to the clinics. This shortcoming reveals …

Nanomedicine is a promising strategy for improving clinical outcomes for cancer therapies,
by improving drug efficacy through enhanced delivery to disease sites. It is of importance for …

Inflammation, a common feature of many diseases, is an essential immune response that
enables survival and maintains tissue homeostasis. However, in some conditions, the …

Uncontrolled inflammatory processes are at the root of numerous pathologies. Most recently,
studies on confirmed COVID-19 cases have suggested that mortality might be due to virally …

Nanotechnology research over the past several decades has been aimed primarily at
improving the physicochemical properties of small molecules to produce druggable …

Inflammatory disease (ID) is a general term that covers all diseases in which chronic
inflammation performs as the major manifestation of pathogenesis. Traditional therapies …

Nanotechnology has revolutionized the field of biomedical sciences with smart approaches
of imaging and treatment. This transformation has led to the development of a new field …

Nanotherapy is a part of nanomedicine that involves nanoparticles as carriers to deliver
drugs to target locations. This novel targeting approach has been found to resolve various …

The intersection of lipid-based nanoparticles and lyotropic liquid crystals has provided a
novel type of nanocarrier system known as 'lipid-based lyotropic liquid crystals' or 'liquid …

In the past decades, for the intermediate or advanced cancerous stages, preclinical and
clinical applications of nanomedicines in cancer theranostics have been extensively studied …